Current Projects: Innovation and Technology Policy

  • Examining Misleading Online Free Trials and Subscription Traps Experienced by European Consumers

    RAND Europe, with GfK Belgium and time.lex, is examining the practice of European businesses offering misleading "free" trials online. The study is also analysing relevant EU legislation and will formulate recommendations to prevent and combat subscription traps.

  • Investigating the Relationship Between R&D Funding and Performance

    To understand more about the implications of these long-term funding restrictions, as well as the potential benefits from increasing research spending, the Department of Business, Innovation and Skills has asked RAND Europe to examine — and thus to improve the government's understanding about — the relationship between the level of research spending and research performance, and particularly how changes in research spending relate to changes in performance.

  • Focusing on Mental Health and Wellbeing

    RAND Europe’s growing work in the field of mental health and wellbeing draws on expertise from across a range of disciplines and methodological backgrounds to bring an innovative perspective to our projects. In particular, our well-established reputation in healthcare research is complemented by extensive science policy expertise, particularly in the field of research evaluation.

  • Identifying Successful Innovations in European Higher Education

    RAND Europe is a co-leading organisation for the Governance and Adaptation to Innovative modes of Higher Education provision project, with 12 partners across the EU. This project for the European Commission and the French Ministry for National Education examines innovative modes in teaching and learning and their evolution across Europe.

  • Innovation, Health and Wealth: A Formative and Summative Evaluation

    The Department of Health’s strategy for improving care and creating greater wealth through innovation, known as ‘Innovation, Health and Wealth’ (IHW), has the potential to systematically change the way the NHS operates. RAND Europe is evaluating whether and how IHW actions are working as planned, and contributing to achieving the strategy's overarching aims.

  • Validating the Outcomes of the 'Science 2.0: Science in Transition' Public Consultation

    ‘Science 2.0’ describes the on-going evolution in the modus operandi of doing research and organising science in Europe. RAND Europe is reviewing the public consultation on this EU project and has developed an interactive website on which participants and interested individuals can comment on the validation process of the public consultation.

  • Mapping the Global Mental Health Research System

    To support the coordination of mental health research, RAND Europe is mapping the research funding ‘ecosystem’. Researchers are exploring who the major funders are, what kinds of research they support, and how their strategies relate to one another.

  • Understanding the Relative Valuations of Research Impact

    To contribute to the Medical Research Council's objective of funding studies that "deliver user/beneficiary views on the contribution of academic research and MRC input," researchers are refining and adapting a survey-based approach known as Best-Worst Scaling (BWS) to analyse the relative valuations of research impact as perceived by the general population and researchers.

  • Exploring the Links Between Big Data and Public Policy

    Understanding the context and impacts of the complex problems associated with big data, as well as related cultural and governance issues and policy frameworks, is important to businesses, governments, research organisations, citizens and policymakers. RAND Europe connects diverse strands across these areas.

  • Evaluating Social Innovation Pilot Projects

    A series of social innovation pilot projects across Europe aim to support the growth of European social finance markets and the development of capacities within social business and young entrepreneurship. RAND Europe and Ecorys are evaluating these pilots and hosting a series of interactive workshops to encourage an exchange of experiences.

  • Evaluating CAPREx, the Cambridge Africa Partnership for Research Excellence

    CAPREx aims to strengthen Africa’s capacity for sustainable excellence in research through close collaborative work with the region’s most talented individuals. RAND Europe is consulting on the evaluation aspects of the initiative, drawing on established subject and methodological expertise in conducting real-time evaluations of networked research and capacity-building efforts, including in African contexts.

  • Understanding Physicians' Decision-Making Process Concerning Hepatitis-C Treatment

    When treating patients for Hepatitis-C, physicians may be influenced by many factors: their prior experience, the health and social care systems more broadly, or clinical, social and behavioural, or demographic factors. To better understand this decision-making process, GlaxoSmithKline commissioned RAND Europe to investigate the comparative influence and importance of specific factors and combinations of factors and their trade-offs.

  • Could the Strengthening of Health Systems in Africa Improve Industrial Development?

    The performance of health systems is a key determinant of the inclusiveness of economic growth. Exclusionary, poor quality health care worsens impoverishment, while inclusive health care redistributes the benefits of growth toward the poor and ill. With Kenya and Tanzania as case studies, RAND Europe is exploring the extent to which unexploited potential synergies between industrial development and health systems can strengthen and contribute to faster and more inclusive growth.

  • Evaluating the Success of Research Collaborations in Improving Applied Health Research

    The National Institute for Health Research established nine Collaborations for Leadership in Applied Health Research and Care (CLAHRCs) and has commissioned RAND Europe and the Health Economics Research Group at Brunel University to evaluate and learn from the CLAHRCs approach. The goal of the project is to focus on the gap in translating applied research advances into innovations in health and social care, for patient benefit.

  • What Impact Will Online Energy-Efficiency Ratings Have on the EU’s Lisbon Strategy?

    The EU's Lisbon Strategy has a targeted goal of 20% energy efficiency gains by 2020. EU Directive 2010/30/EC has therefore mandated energy efficiency labels on a wider variety of products than was previously the case and further requires this information to be made available online. RAND Europe is assessing the impacts of measures intended to implement this requirement by ensuring that A-G Energy Efficiency rating information is displayed in online sales, rental, and search environments.

  • Assessing the Evidence Base for Pharmaceutical R&D Models

    As research-based drug development is widely viewed as crucial to improving patient health, the pharmaceuticals sector is heavily reliant — and spends a great deal — on research and development. However, there is considerable debate about different R&D models: for example, is it more successful when conducted in a closed, in-house environment or through open networks and partnerships? To help answer this question, Pfizer has asked RAND Europe to investigate the evidence base.